🚀 VC round data is live in beta, check it out!
abrdn Life Sciences Valuation Multiples
Discover revenue and EBITDA valuation multiples for abrdn Life Sciences and similar public comparables like Crescent Capital BDC, Testa Residencial, Qualitas, Djerriwarrh Investments and more.
abrdn Life Sciences Overview
About abrdn Life Sciences
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund’s Investment Adviser to have the potential for above-average growth.
Founded
1992
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$493M
abrdn Life Sciences Financials
abrdn Life Sciences reported last fiscal year revenue of $86M.
In the same fiscal year, abrdn Life Sciences generated $86M in net income.
abrdn Life Sciences P&L
In the most recent fiscal year, abrdn Life Sciences reported revenue of $86M and net income of $86M.
abrdn Life Sciences expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $86M | XXX | XXX | XXX |
| Net Profit | — | XXX | $86M | XXX | XXX | XXX |
| Net Margin | — | XXX | 99% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
abrdn Life Sciences Stock Performance
abrdn Life Sciences has current market cap of $493M, and enterprise value of $493M.
Market Cap Evolution
abrdn Life Sciences' stock price is $16.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $493M | $493M | 0.0% | XXX | XXX | XXX | $2.89 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Trialabrdn Life Sciences Valuation Multiples
abrdn Life Sciences trades at 5.7x EV/Revenue multiple.
abrdn Life Sciences Financial Valuation Multiples
As of April 10, 2026, abrdn Life Sciences has market cap of $493M and EV of $493M.
Equity research analysts estimate abrdn Life Sciences' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
abrdn Life Sciences has a P/E ratio of 5.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $493M | XXX | $493M | XXX | XXX | XXX |
| EV (current) | $493M | XXX | $493M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 5.7x | XXX | XXX | XXX |
| P/E | — | XXX | 5.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified abrdn Life Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
abrdn Life Sciences Margins & Growth Rates
abrdn Life Sciences' revenue in the last fiscal year declined by (0%).
abrdn Life Sciences Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (0%) | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
abrdn Life Sciences Public Comps
See public comps and valuation multiples for other Asset Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Crescent Capital BDC | XXX | XXX | XXX | XXX | XXX | XXX |
| Testa Residencial | XXX | XXX | XXX | XXX | XXX | XXX |
| Qualitas | XXX | XXX | XXX | XXX | XXX | XXX |
| Djerriwarrh Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Fidere Patrimonio Socimi | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
abrdn Life Sciences M&A Activity
abrdn Life Sciences acquired XXX companies to date.
Last acquisition by abrdn Life Sciences was on XXXXXXXX, XXXXX. abrdn Life Sciences acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by abrdn Life Sciences
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free Trialabrdn Life Sciences Investment Activity
abrdn Life Sciences invested in XXX companies to date.
abrdn Life Sciences made its latest investment on XXXXXXXX, XXXXX. abrdn Life Sciences invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by abrdn Life Sciences
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout abrdn Life Sciences
| When was abrdn Life Sciences founded? | abrdn Life Sciences was founded in 1992. |
| Where is abrdn Life Sciences headquartered? | abrdn Life Sciences is headquartered in United States. |
| Is abrdn Life Sciences publicly listed? | Yes, abrdn Life Sciences is a public company listed on NYSE. |
| What is the stock symbol of abrdn Life Sciences? | abrdn Life Sciences trades under HQL ticker. |
| Who are competitors of abrdn Life Sciences? | abrdn Life Sciences main competitors are Crescent Capital BDC, Testa Residencial, Qualitas, Djerriwarrh Investments. |
| What is the current market cap of abrdn Life Sciences? | abrdn Life Sciences' current market cap is $493M. |
| What is the current revenue of abrdn Life Sciences? | abrdn Life Sciences' last fiscal year revenue is $86M. |
| What is the current EV/Revenue multiple of abrdn Life Sciences? | Current revenue multiple of abrdn Life Sciences is 5.7x. |
| Is abrdn Life Sciences profitable? | No, abrdn Life Sciences is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.